Menadione serves as a substrate for P-glycoprotein: Implication in chemosensitizing activity

Archives of Pharmacal Research

Volumn 36, Issue 4, 2013, Pages 509-516

  Oh, Seok Jeong ^a   Han, Hyo Kyung ^a   Kang, Keon Wook ^b   Lee, Young Joo ^c   Lee, Moo Yeol ^a  

^a Dongguk University   (South Korea)

^b Seoul National University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Chemotherapeutics; Cytotoxicity; Drug resistance; Menadione; P glycoprotein; Vitamin Ks

Indexed keywords

MENADIONE; MULTIDRUG RESISTANCE PROTEIN; QUINIDINE; RHODAMINE 123; VERAPAMIL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG CYTOTOXICITY; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FLUORESCENT DYES; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MCF-7 CELLS; P-GLYCOPROTEIN; QUINIDINE; RHODAMINE 123; TRANSFECTION; VERAPAMIL; VITAMIN K 3;

EID: 84877876152     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0052-3     Document Type: Article

References (36)

1. Akman, S.A., M. Dietrich, R. Chlebowski, P. Limberg, and J.B. Block. 1985. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool. Cancer Research 45: 5257-5262.
2. Akman, S.A., J.H. Doroshow, M.F. Dietrich, R.T. Chlebowski, and J.S. Block. 1987. Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210. Journal of Pharmacology and Experimental Therapeutics 240: 486-491.
3. Altenberg, G.A., C.G. Vanoye, J.K. Horton, and L. Reuss. 1994. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: Evidence against direct drug extrusion from the plasma membrane. Proc Natl Acad Sci U S A 91: 4654-4657.
4. Borst, P., and R.O. Elferink. 2002. Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 71: 537-592.
5. Cai, Y., J. Lu, Z. Miao, L. Lin, and J. Ding. 2007. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biology & Therapy 6: 1794-1799.
6. Chung, S.H., S.M. Chung, J.Y. Lee, S.R. Kim, K.S. Park, and J.H. Chung. 1999. The biological significance of non-enzymatic reaction of menadione with plasma thiols: Enhancement of menadione-induced cytotoxicity to platelets by the presence of blood plasma. FEBS Letters 449: 235-240.
7. Chung, S.M., J.Y. Lee, M.Y. Lee, O.N. Bae, and J.H. Chung. 2001. Adverse consequences of erythrocyte exposure to menadione: Involvement of reactive oxygen species generation in plasma. Journal of Toxicology and Environmental Health A 63: 617-629.
8. Cranenburg, E.C., L.J. Schurgers, and C. Vermeer. 2007. Vitamin K: The coagulation vitamin that became omnipotent. Thrombosis and Haemostasis 98: 120-125.
9. Deeley, R.G., C. Westlake, and S.P. Cole. 2006. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiological Reviews 86: 849-899.
10. Evers, R., M. Kool, A.J. Smith, L. Van Deemter, M. De Haas, and P. Borst. 2000. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. British Journal of Cancer 83: 366-374.
11. Higgins, C.F. 2007. Multiple molecular mechanisms for multidrug resistance transporters. Nature 446: 749-757.
12. Hitomi, M., F. Yokoyama, Y. Kita, T. Nonomura, T. Masaki, H. Yoshiji, H. Inoue, F. Kinekawa, K. Kurokohchi, N. Uchida, S. Watanabe, and S. Kuriyama. 2005. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology 26: 713-720.
13. Im, Y.B., I. Ha, K.W. Kang, M.Y. Lee, and H.K. Han. 2009. Macelignan: A new modulator of P-glycoprotein in multidrug-resistant cancer cells. Nutrition and Cancer 61: 538-543.
14. Lamson, D.W., and S.M. Plaza. 2003. The anticancer effects of vitamin K. Alternative Medicine Review 8: 303-318.
15. Lee, M.Y., O.N. Bae, S.M. Chung, K.T. Kang, J.Y. Lee, and J.H. Chung. 2002. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: A contributing factor to cardiovascular disease. Toxicology and Applied Pharmacology 179: 83-88.
16. Lee, M.Y., A. San Martin, P.K. Mehta, A.E. Dikalova, A.M. Garrido, S.R. Datla, E. Lyons, K.H. Krause, B. Banfi, J.D. Lambeth, B. Lassegue, and K.K. Griendling. 2009. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 480-487.
17. Liao, W.C., F.Y. Wu, and C.W. Wu. 2000. Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells. International Journal of Oncology 17: 323-328.
18. Liscovitch, M., and D. Ravid. 2007. A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Letters 245: 350-352.
19. Margolin, K.A., S.A. Akman, L.A. Leong, R.J. Morgan, G. Somlo, J.W. Raschko, C. Ahn, and J.H. Doroshow. 1995. Phase I study of mitomycin C and menadione in advanced solid tumors. Cancer Chemotherapy and Pharmacology 36: 293-298.
20. Matzno, S., Y. Yamaguchi, T. Akiyoshi, T. Nakabayashi, and K. Matsuyama. 2008. An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents. Biological and Pharmaceutical Bulletin 31: 1270-1273.
21. Nutter, L.M., A.L. Cheng, H.L. Hung, R.K. Hsieh, E.O. Ngo, and T.W. Liu. 1991. Menadione: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochemical Pharmacology 41: 1283-1292.
22. Parekh, H.K., H. Mansuri-Torshizi, T.S. Srivastava, and M.P. Chitnis. 1992. Circumvention of adriamycin resistance: Effect of 2-methyl-1,4- naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Cancer Letters 61: 147-156.
23. Seung, S.A., J.Y. Lee, M.Y. Lee, J.S. Park, and J.H. Chung. 1998. The relative importance of oxidative stress versus arylation in the mechanism of quinone-induced cytotoxicity to platelets. Chemico-Biological Interactions 113: 133-144.
24. Sheps, J.A., and V. Ling. 2007. Preface: The concept and consequences of multidrug resistance. Pflugers Archiv. European Journal of Physiology 453: 545-553.
25. Shirasaka, Y., R. Konishi, N. Funami, Y. Kadowaki, Y. Nagai, T. Sakaeda, and S. Yamashita. 2009. Expression levels of human P-glycoprotein in in vitro cell lines: Correlation between mRNA and protein levels for P-glycoprotein expressed in cells. Biopharmaceutics & Drug Disposition 30: 149-152.
26. Shukla, S., C.P. Wu, K. Nandigama, and S.V. Ambudkar. 2007. The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Molecular Cancer Therapeutics 6: 3279-3286.
27. Simon, S.M., and M. Schindler. 1994. Cell biological mechanisms of multidrug resistance in tumors. Proceedings of the National Academy of Sciences of the United States of America 91: 3497-3504.
28. Szakacs, G., J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman. 2006. Targeting multidrug resistance in cancer. Natue Reviews Drug Discovery 5: 219-234.
29. Takahashi, K., T. Shibata, T. Oba, T. Ishikawa, M. Yoshikawa, R. Tatsunami, and Y. Tampo. 2009. Multidrug-resistance-associated protein plays a protective role in menadione-induced oxidative stress in endothelial cells. Life Sciences 84: 211-217.
30. Vermeer, C., M.J. Shearer, A. Zittermann, C. Bolton-Smith, P. Szulc, S. Hodges, P. Walter, W. Rambeck, E. Stocklin, and P. Weber. 2004. Beyond deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health. European Journal of Nutrition 43: 325-335.
31. Wartenberg, M., K. Fischer, J. Hescheler, and H. Sauer. 2000. Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids. International Journal of Cancer 85: 267-274.
32. Waxman, S., and H. Bruckner. 1982. The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol. European Journal of Cancer & Clinical Oncology 18: 685-692.
33. Wu, F.Y., W.C. Liao, and H.M. Chang. 1993. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sciences 52: 1797-1804.
34. Wu, J., H. Ji, Y.Y. Wang, Y. Wang, Y.Q. Li, W.G. Li, Y. Long, Y.Z. Xia, and H. Hong. 2009. Glutathione depletion upregulates P-glycoprotein expression at the blood-brain barrier in rats. Journal of Pharmacy and Pharmacology 61: 819-824.
35. Zhang, J., F. Zhou, X. Wu, X. Zhang, Y. Chen, B.S. Zha, F. Niu, M. Lu, G. Hao, Y. Sun, J. Sun, Y. Peng, and G. Wang. 2012. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. British Journal of Pharmacology 165: 120-134.
36. Zhou, S.F. 2008. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38: 802-832.